{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Stability&page=36", "query": { "condition": "Stability", "page": 36 }, "page_size": 10 }, "pagination": { "page": 36, "page_size": 10, "total_count": 979, "total_pages": 98, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Stability&page=37&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Stability&page=35&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T16:22:31.022Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01962922", "title": "Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Failure" ], "interventions": [ { "name": "LCP-Tacro", "type": "DRUG" }, { "name": "Tacrolimus -IR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Veloxis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2013-11", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 3, "location_summary": "Chicago, Illinois • St Louis, Missouri • Philadelphia, Pennsylvania", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01962922" }, { "nct_id": "NCT02476396", "title": "Structural Stability of Carotid Plaque and Symptomatology", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Carotid Stenosis", "Stroke", "Carotid Artery Plaque", "Transient Ischemic Attack", "Cerebrovascular Accident", "Carotid Artery Stenosis" ], "interventions": [ { "name": "Carotid Endarterectomy or Stenting", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 176, "start_date": "2015-11-09", "completion_date": "2024-07-14", "has_results": false, "last_update_posted_date": "2024-08-16", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02476396" }, { "nct_id": "NCT01568203", "title": "First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "AMG 579", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 50, "start_date": "2011-09", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2012-10-10", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01568203" }, { "nct_id": "NCT02751294", "title": "A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria, Vivax" ], "interventions": [ { "name": "Tafenoquine Control", "type": "DRUG" }, { "name": "Tafenoquine dissolution profile X", "type": "DRUG" }, { "name": "Tafenoquine SIL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 14, "start_date": "2016-05", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02751294" }, { "nct_id": "NCT04361162", "title": "Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer", "Metastatic Pancreatic Cancer" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" }, { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2020-05-18", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2022-09-08", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 3, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04361162" }, { "nct_id": "NCT01879722", "title": "Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "TAK-063", "type": "DRUG" }, { "name": "TAK-063 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 77, "start_date": "2013-06", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01879722" }, { "nct_id": "NCT00227019", "title": "Phase 2 Trial of Bevacizumab in Combination With Pemetrexed", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer (NSCLC)", "Lung Cancer", "Neoplasm Metastasis" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Vitamin B12", "type": "DRUG" }, { "name": "Folate", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heather Wakelee", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2006-03", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2017-03-06", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 4, "location_summary": "Stanford, California • Lebanon, New Hampshire • Voorhees Township, New Jersey + 1 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Voorhees Township", "state": "New Jersey" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00227019" }, { "nct_id": "NCT04798430", "title": "Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease With Mention of Arteriosclerosis", "Elevated Cholesterol", "Familial Hypercholesterolemia" ], "interventions": [ { "name": "lerodalcibep", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LIB Therapeutics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 2000, "start_date": "2020-12-03", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2024-10-22", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 4, "location_summary": "Evanston, Illinois • Cincinnati, Ohio", "locations": [ { "city": "Evanston", "state": "Illinois" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04798430" }, { "nct_id": "NCT03834155", "title": "Enhancing Cardiac Rehabilitation Through Behavioral Nudges", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Myocardial Infarction", "Percutaneous Coronary Intervention", "Coronary Artery Disease", "Valvular Disease", "Chronic Stable Angina", "Chronic Stable Heart Failure" ], "interventions": [ { "name": "Hospital-based CR + Movn Application", "type": "OTHER" }, { "name": "Choice of Hospital or home-based CR + Movn Application", "type": "OTHER" }, { "name": "Hospital-based CR + Movn Application + Nudge", "type": "OTHER" }, { "name": "Choice of Hospital or home-based CR + Movn Application + Nudge", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Denver Health and Hospital Authority", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 447, "start_date": "2019-05-17", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2025-05-13", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03834155" }, { "nct_id": "NCT00713284", "title": "Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Renal Transplantation" ], "interventions": [ { "name": "sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "California Pacific Medical Center Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2007-05", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2020-10-27", "last_synced_at": "2026-10-24T16:22:31.022Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00713284" } ] }